Ritivel YC 지원서

Winter 2026Active

Ritivel은(는) Winter 2026 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Winter 2026
산업: HealthcareHealthcare IT
팀 규모: 3
상태: Active
출시됨: 2026

창업자

Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder

Ritivel의 사업 내용

Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.

Ritivel의 YC 지원서, 재구성됨

Y Combinator 지원

Ritivel, Winter 2026 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Ritivel

Describe what your company does in 50 characters or less.

AI-native platform for Life-Sciences Documentation

What is your company going to make? Please describe your product and what it does or will do.

We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.

Where do you live now, and where would the company be based after YC?

We live in San Francisco and plan to keep the company based here after YC as well.

Explain your decision regarding location.

San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Ritivel의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Ritivel의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Ritivel과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.